Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial ; volume:10 ; number:1 ; day:11 ; month:4 ; year:2011 ; pages:1-10 ; date:12.2011
Annals of general psychiatry ; 10, Heft 1 (11.4.2011), 1-10, 12.2011
- Creator
-
Alphs, Larry
Bossie, Cynthia A.
Sliwa, Jennifer K.
Ma, Yi-Wen
Turner, Norris
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1744-859X-10-12
- URN
-
urn:nbn:de:101:1-2019071902283578192786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alphs, Larry
- Bossie, Cynthia A.
- Sliwa, Jennifer K.
- Ma, Yi-Wen
- Turner, Norris
- SpringerLink (Online service)
Other Objects (12)
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy